Glenn Alfons Friedrich
Chief Operating Officer at Kymab Ltd.
Profile
Glenn Alfons Friedrich is the founder of Ceros Pharmaceuticals, Inc. (founded in 2000).
He is currently the Director at Wrnch, Inc. and the Chief Operating Officer at Kymab Ltd.
(since 2014).
Previously, he worked as a Senior Research Director at BCM Technologies, Inc. (2005-2007), a Senior Scientist at Lexicon Pharmaceuticals, Inc., and a Principal at Progression Therapeutics, Inc. Dr. Friedrich completed his undergraduate degree at the University of Alberta and holds a doctorate from Baylor College of Medicine.
Glenn Alfons Friedrich active positions
| Companies | Position | Start |
|---|---|---|
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Chief Operating Officer | - |
Wrnch, Inc.
 Wrnch, Inc. Packaged SoftwareTechnology Services Wrnch, Inc. operates as computer vision Software Company. It is an automated human motion capture system that takes 2D video and outputs 3D skeletonal animation data. The company was founded by Paul Kruszewski and is headquartered in Montreal, Canada. | Director/Board Member | - |
Former positions of Glenn Alfons Friedrich
| Companies | Position | End |
|---|---|---|
BCM Technologies, Inc.
 BCM Technologies, Inc. Investment ManagersFinance BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas. | Director of Research - Equity | 2006-12-31 |
| LEXICON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Progression Therapeutics, Inc.
 Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX. | Director/Board Member | - |
Ceros Pharmaceuticals, Inc.
 Ceros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceros Pharmaceuticals, Inc. develops compounds to treat osteoporosis. The company is based in Houston, TX. The company was founded by Glenn Alfons Friedrich. Ceros Pharmaceuticals was acquired by Auxeris Therapeutics, Inc. on January 14, 2004. | Founder | - |
Training of Glenn Alfons Friedrich
| University of Alberta | Undergraduate Degree |
| Baylor College of Medicine | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
BCM Technologies, Inc.
BCM Technologies, Inc. Investment ManagersFinance BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas. | Finance |
Ceros Pharmaceuticals, Inc.
Ceros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceros Pharmaceuticals, Inc. develops compounds to treat osteoporosis. The company is based in Houston, TX. The company was founded by Glenn Alfons Friedrich. Ceros Pharmaceuticals was acquired by Auxeris Therapeutics, Inc. on January 14, 2004. | Health Technology |
Progression Therapeutics, Inc.
Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX. | Health Technology |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Wrnch, Inc.
Wrnch, Inc. Packaged SoftwareTechnology Services Wrnch, Inc. operates as computer vision Software Company. It is an automated human motion capture system that takes 2D video and outputs 3D skeletonal animation data. The company was founded by Paul Kruszewski and is headquartered in Montreal, Canada. | Technology Services |
- Stock Market
- Insiders
- Glenn Alfons Friedrich
